Cite
HARVARD Citation
Schiff, M. et al. (2014). AB0438 Efficacy and Safety of Tabalumab, an Anti-B Cell Activating Factor Monoclonal Antibody, in Patients with Rheumatoid Arthritis WHO HAD an Inadequate Response to Tnf-Alpha Inhibitors: Results from A Phase 3 Multicenter, Randomized, Double-Blind Study. Annals of the rheumatic diseases. pp. 952-953. [Online].